Загрузка...
Acute toxicity of cyclooxygenase-2 inhibitor rofecoxib as a radiosensitizer for concurrent chemoradiation in the treatment of uterine cervical cancer
OBJECTIVE: To evaluate the acute toxicity of rofecoxib during concurrent use with cisplatin-based chemoradiotherapy (CCRT) in patients with cervical cancer. METHODS: We evaluated 67 FIGO stage IB2-IVA cervical cancer patients treated with CCRT between June 2002 and July 2004. The study group include...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Society of Gynecologic Oncology and Colposcopy
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2757559/ https://ncbi.nlm.nih.gov/pubmed/19809548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2009.20.3.151 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|